mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.02 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.02 |
mRNA |
JW-7-24-1 |
GDSC1000 |
pan-cancer |
AAC |
0.072 |
0.02 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.072 |
0.02 |
mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.02 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |